The primary differentiating features between NMO and other non-compressive myelopathies include the extent and severity of spinal cord involvement and the presence of aquaporin-4 antibodies, which are typically positive in NMO but negative in other conditions. This evidence concerns the gene AQP4 and neuromyelitis optica.